Lobe Sciences Ltd.
LOBEF
$0.027
-$0.0005-1.82%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 99.80K | 730.50K | 730.50K | 730.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 99.80K | 730.50K | 730.50K | 730.50K |
| Cost of Revenue | 11.20K | 12.50K | 19.30K | 19.30K | 19.30K |
| Gross Profit | -11.20K | 87.30K | 711.20K | 711.20K | 711.20K |
| SG&A Expenses | 1.43M | 1.31M | 1.70M | 1.91M | 2.02M |
| Depreciation & Amortization | 41.70K | 62.40K | 80.90K | 73.00K | 52.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.63M | 1.67M | 2.83M | 2.66M | 2.95M |
| Operating Income | -1.63M | -1.57M | -2.10M | -1.93M | -2.22M |
| Income Before Tax | -3.38M | -3.22M | -2.05M | -1.97M | -2.27M |
| Income Tax Expenses | 24.10K | 24.10K | 153.80K | 153.80K | 153.80K |
| Earnings from Continuing Operations | -3.41 | -3.24 | -2.20 | -2.12 | -2.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.41M | -3.24M | -2.20M | -2.12M | -2.42M |
| EBIT | -1.63M | -1.57M | -2.10M | -1.93M | -2.22M |
| EBITDA | -1.57M | -1.51M | -2.01M | -1.85M | -2.17M |
| EPS Basic | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 582.52M | 487.96M | 475.52M | 431.04M | 428.74M |
| Average Diluted Shares Outstanding | 582.52M | 487.96M | 475.52M | 431.04M | 428.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |